Any current/future new fundraising through debt or equity?

UPL Limited is planning a rights issue expected to close positively within the financial year FY '25, targeting completion by end of Q3 or mid Q4 2024. (Page 10, Page 3) The rights issue is underwritten by the promoter group, who have committed to subscribing fully as per SEBI guidelines. (Page 10) The company is evaluating monetization of some platforms alongside the rights issue. (Page 3) There is no current decision on calling or refinancing the U.S. dollar perpetual bonds callable in February next year; however, the company may use free cash flow and rights issue proceeds to reduce debt, w

Future growth expectations in sales/revenue/volumes?

UPL expects full-year FY '25 revenue growth in the range of 4% to 8%, driven largely by volume gains. Volume growth was strong in Q1 at 16%, supported by good in-season demand and destocking completion. New product launches targeting differentiated and sustainable products aim to contribute $85 million in revenue this year. The Indian business expects growth to normalize with better monsoon outlook and new product introductions, though sales phasing may shift due to tighter credit norms. North America showed strong volume-led growth (up 25% in Q1), expected to normalize but sustain goi

UPLQ1 FY25Fertilizers & Agrochemicals

UPL Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹517P/E: 23.5Market Cap: ₹46.4K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 4

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

N/A

2 of 3 growth signals are positive.

Full analysis

Revenue guidance

Category 4

UPL expects full-year FY '25 revenue growth in the range of 4% to 8%, driven largely by volume gains.
Volume growth was strong in Q1 at 16%, supported by good in-season demand and destocking completion.
New product launches targeting differentiated and sustainable products aim to contribute $85 million in revenue this year.
The Indian business expects growth to normalize with better monsoon outlook and new product introductions, though sales phasing may shift due to tighter credit norms.
North America showed strong volume-led growth (up 25% in Q1), expected to normalize but sustain going forward.
Europe and Latin America see good volume growth despite some price erosion.
Overall, good volume growth across regions is expected for the rest of FY '25, supported by stabilized prices and cost improvements.
EBITDA growth is targeted at greater than 50% over FY '24, reflecting margin improvement from price stabilization and lower costs.

Margin guidance

Category 1

- UPL expects EBITDA growth of greater than 50% over FY '24 (Page 3). - Revenue growth guidance for FY '25 is in the range of 4% to 8%, largely driven by volume (Page 3). - Margin improvement anticipated in the second half of FY '25, supported by pricing stabilization and lower input costs (Pages 4, 7, 16). - Contribution margins normalized close to 40%, showing stabilization after prior declines (Page 7). - High-cost inventory being liquidated, aiding sequential margin improvement through the year (Pages 5, 7). - Cost optimization efforts targeting $100 million savings in FY '25, supporting profitability (Page 9). - Pricing headwinds expected to largely disappear by second half FY '25, further boosting margins (Page 14). - Cash flow from operations guidance of $300-$400 million for FY '25, enabling deleveraging and financial strength (Page 3). Overall, UPL is confident of a strong recovery in profits and EPS in FY '25, driven by volume growth, stabilized prices, cost savings, and margin improvement.

See what UPL management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

UPL Limited is planning a rights issue expected to close positively within the financial year FY '25, targeting completion by end of Q3 or mid Q4 2024. (Page 10, Page 3)
The rights issue is underwritten by the promoter group, who have committed to subscribing fully as per SEBI guidelines. (Page 10)
The company is evaluating monetization of some platforms alongside the rights issue. (Page 3)
There is no current decision on calling or refinancing the U.S. dollar perpetual bonds callable in February next year; however, the company may use free cash flow and rights issue proceeds to reduce debt, with actions dependent on debt cost considerations. (Page 11)
The company is focused on deleveraging and reducing interest costs, with guidance to reduce net debt by $300-$400 million in FY '25 excluding rights issue proceeds. (Page 8, Page 3)

Order book

The transcript in the provided pages does not specifically mention current or expected order book or pending orders for UPL Limited. However, some related insights from the call include: - Sales in UPL SAS (India business) were impacted due to tighter credit and inventory norms, leading to a shift in sales phasing rather than decline. - Growth in volumes was strong in several regions, especially in North America and Latin America, indicating robust demand. - The company expects larger market seasons to begin from end-Q2 through Q3 and Q4, supporting revenue and EBITDA growth. - Volume growth and price stabilization suggest improving business momentum. - No explicit quantified order book or pending order details were shared during the call. For precise current or expected order book numbers, a direct company update or dedicated financial report would be needed.

See what UPL management said on order book — free account, 30 seconds.

Capex plans

The transcript provided does not explicitly mention any current or future capex, capital investment, or strategic investment plans in detail. However, here are some relevant points related to investments and strategic moves: - The company is focused on cost optimization, targeting $100 million savings in FY '25 through operational efficiencies including SG&A reduction and setting up a global business service center. - Discussion on monetization of some platforms is ongoing, indicating evaluation of strategic options. - Rights issue is planned to close within the financial year to strengthen the balance sheet and generate cash, potentially supporting deleveraging and investments. - No explicit mention of new capex or capital investment projects. - Emphasis on new product launches expected to generate $85 million revenue, indicating investment in product development and innovation. - Ongoing restructuring and optimization in the India Crop Protection platform focusing on tightening credit and working capital. Overall, focus is on operational efficiency, product pipeline, and financial strengthening rather than large new capital expenditures.

Track UPL — get its next earnings analysis in your feed

How does UPL rank vs peers in Fertilizers & Agrochemicals?

Pro feature

ThisUPL

Rev 4Mar 1

See where UPL sits in Fertilizers & AgrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does UPL rank in Fertilizers & Agrochemicals?

Compare UPL against every Fertilizers & Agrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Fertilizers & Agrochemicals leaderboard →

What UPL's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q4 FY26)
Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…
Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…
Bhagiradha Chemicals & Industries Ltd (Q4 FY26)
158.1 crores . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Bhagiradha Chemicals & Industries Ltd (Q1 FY27)
195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs P I Industries

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →